Genflow Biosciences PLC is a UK-based biotechnology company developing gene therapies designed to target the ageing process and to reduce and delay the incidence of age-related diseases.
This will be done through novel therapeutics targeting aging in humans by using adeno associated virus (AAV) vectors to deliver copies of the Sirtuin-6 (SIRT6) gene variant that is found in centenarians into cells.
